IREN's $20.3 Billion Order Book Is Signed — the Question Is Who Pays for the Build

IREN shares have been on a tear this week, and the trigger came from outside the company. CoreWeave's latest results eased investor anxiety about demand and financing across the AI cloud complex, lifting the whole group — IREN included. The stock climbed 6.4% on Wednesday and was up another 8.9% as the friendlier mood held, according to media reports.

The rally makes sense on the surface. When the market marks down sector-wide risk, companies with ambitious build-out plans get a better hearing. But for IREN, the sector tailwind lands on top of a very specific set of promises — and those promises now carry a price tag that investors are only beginning to price in.

A $4 Billion Target, a Moving Deadline

Roughly a week ago, IREN said its goal of more than US$4 billion in annualized recurring revenue is fully contracted and financed. The target date is January 2027, though the company has flagged that delivery could stretch into February. The slip from an earlier end-2026 timeline was put down to a customer-requested design change and supplier scheduling.

That explanation shifts the spotlight squarely onto execution. The contracted base is the strongest argument in IREN's favor — it gives the expansion a firmer footing than a pure demand bet. But its value to shareholders only crystallizes if the capacity arrives inside the promised window. Financing and delivery have to be judged together, not separately.

The Funding Gap Is the Real Test

Here is where the story gets more complicated. IREN has pegged capital spending for the remaining months of fiscal 2027 at roughly US$15 billion. About US$9 billion is covered by liquid resources, financing commitments and customer prepayments. That leaves some US$6 billion still to be sourced.

Should investors sell immediately? Or is it worth buying IREN?

How that gap gets closed will shape the equity story. Secure it on workable terms and IREN can push ahead with its contracted expansion. If fresh equity is needed, shareholders must weigh growth against dilution. Lean more heavily on debt, and interest costs and repayment terms move to the foreground.

The order book stands at US$20.3 billion. By the company's own account, about two-thirds is tied to investment-grade customers or guarantees. On the newest five-year contract, a customer prepayment covers 90% of the associated GPU investment. Broader use of such prepayments would be especially valuable to shareholders, since it shrinks the capital IREN must front before revenue lands.

Contract Pricing Is Moving in IREN's Favor

The terms on recent deals offer a glimpse of what a healthier funding mix could look like. IREN cites US$22 million per megawatt on a five-year contract and US$40 million on a short-term agreement. The Microsoft deal struck last year came in at US$9.7 million per megawatt.

If comparable pricing holds on future signings, IREN could underwrite its expansion on stronger economics. The most attractive combination would pair higher contract prices with large prepayments — customers strengthening the revenue outlook while absorbing part of the capital outlay. Whether further agreements deliver similar terms is the open question, and a big backlog only helps the funding picture when it converts into timely customer cash.

Growth Is Real — So Are the Losses

The operating momentum gives that scenario something to build on. AI cloud revenue hit roughly US$200 million in the first quarter of fiscal 2027, up from US$71 million in the prior quarter, with an AI gross margin of 86%. Total revenue for the quarter came in at US$228 million.

Yet the same quarter carried a net loss of US$263 million. Operating cash flow of US$529 million included US$645 million of prepayments, while US$4.8 billion went into capital expenditure. At the end of September, IREN carried US$9.9 billion in debt against US$18.9 billion of open purchase obligations.

Prepayments help fund the build but bind IREN to delivering later. If shipments slip or commissioning drags, the company holds capital longer — a risk that grows for as long as substantial further spending remains to be financed. For a lasting re-rating, the revenue and margin momentum has to reach the bottom line, with depreciation, financing and ongoing construction not swallowing the incremental earnings.

IREN at a turning point? This analysis reveals what investors need to know now.

Two Brokerages, One Cautious Message

Wall Street is sending a mixed signal. Goldman Sachs cut its price target from US$50 to US$30 and stayed at "Neutral." JPMorgan reaffirmed "Overweight" on Monday but trimmed its target from US$65 to US$55. Read together, the pair point to a broadly positive view on growth paired with more restrained valuations.

That tension fits IREN's position. The contracted and financed revenue ambition and the improved sector backdrop both argue in the company's favor — and both gain weight if IREN delivers the build-out reliably. CoreWeave CEO Michael Intrator told CNBC that available capacity for 2027 is oversubscribed tenfold, a bullish industry signal so long as the demand translates into economically attractive contracts.

January Becomes the Operational Exam

The next company-specific checkpoint is the more than US$4 billion annualized revenue target in January 2027, possibly slipping to the end of February. Management has said the build-out behind it is contracted and financed.

Investors should demand two things together: delivery on that revenue pace, and coverage for the investments still unfunded beyond it. If both fall into place, the growth story could firm up financially. If either lags, the capital structure is likely to cap how much valuation room the stock can command. The recovery is understandable — but the next gain in confidence has to come from execution, not from the sector's mood.

Ad

IREN Stock: New Analysis - 12 November

Fresh IREN information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IREN analysis...